ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
68,155.94
-1.37%
S&P 500
5,320.36
0.25%
Dow Jones
39,414.19
-0.65%
US Dollar vs Yen
157.1015
0.25%
Brent Oil
81.48
-0.06%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Landos Biopharma Inc (LABP)

  7. Landos Biopharma Inc (LABP) ニュース

LABP

Landos Biopharma (LABP)

Landos Biopharma Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:LABP
日付受信時刻ニュースソース見出しコード企業名
2024/05/0921 : 32Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LABPLandos Biopharma Inc
2024/03/2521 : 31PR Newswire (US)AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune DiseasesNASDAQ:LABPLandos Biopharma Inc
2024/03/2521 : 30GlobeNewswire Inc.AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune DiseasesNASDAQ:LABPLandos Biopharma Inc
2024/03/0506 : 14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABPLandos Biopharma Inc
2024/03/0506 : 06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABPLandos Biopharma Inc
2024/02/1506 : 01Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:LABPLandos Biopharma Inc
2024/01/0422 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABPLandos Biopharma Inc
2023/11/2122 : 08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABPLandos Biopharma Inc
2023/11/0922 : 22Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LABPLandos Biopharma Inc
2023/11/0922 : 08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABPLandos Biopharma Inc
2023/09/2121 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABPLandos Biopharma Inc
2023/09/1421 : 11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABPLandos Biopharma Inc
2023/08/0921 : 18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LABPLandos Biopharma Inc
2023/08/0921 : 12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABPLandos Biopharma Inc
2023/06/0205 : 20Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:LABPLandos Biopharma Inc
2023/05/2605 : 20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LABPLandos Biopharma Inc
2023/05/2506 : 58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LABPLandos Biopharma Inc
2023/05/2506 : 56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LABPLandos Biopharma Inc
2023/05/2506 : 54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LABPLandos Biopharma Inc
2023/05/2506 : 52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LABPLandos Biopharma Inc
2023/05/2506 : 50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LABPLandos Biopharma Inc
2023/05/1221 : 48Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:LABPLandos Biopharma Inc
2023/05/1221 : 41Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LABPLandos Biopharma Inc
2023/04/1921 : 06Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:LABPLandos Biopharma Inc
2023/04/1921 : 01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:LABPLandos Biopharma Inc
2023/03/3106 : 28Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:LABPLandos Biopharma Inc
2023/03/2321 : 58Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:LABPLandos Biopharma Inc
2023/03/2321 : 31Edgar (US Regulatory)Annual Report (10-k)NASDAQ:LABPLandos Biopharma Inc
2023/03/2321 : 16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LABPLandos Biopharma Inc
2023/03/0306 : 14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LABPLandos Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:LABP

最近閲覧した銘柄

EU
7457T
7457T
BIT
UB30DS
UniCredit Bank
COIN
PITCHUSD
PITCH
KUCN
GAMMAUSDT
Gamma
BFNX
POYBTC
USOTC
AOIFF
Africa Oil (PK)
USOTC
ARMM
ARMM (CE)
BOV
MTRE3Q
MITRE REALTY ON
BIT
UC4KT3
Unicredit Bank
BIT
UC63GV
Unicredit Bank
ASX
FXUKOR
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有